Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Alcohol drinking even in small amount raises risk of steatotic liver disease

05 Mar 2026

Even light or moderate consumption of alcohol can still increase the risk of steatotic liver disease (SLD) and its metabolic dysfunction-associated subtype (MASLD), suggests a study. Furthermore, a gut microbial score based on alcohol-associated species predicts a higher disease risk.

Alcohol drinking even in small amount raises risk of steatotic liver disease

05 Mar 2026

Immune-related AEs linked to better outcomes in HCC patients

02 Mar 2026

Patients with hepatocellular carcinoma (HCC) who develop immune-related adverse events (irAEs) following treatment with an immune checkpoint inhibitor (ICI) tend to have more favourable clinical outcomes, including better progression free survival (PFS) and objective response rate (ORR), reports a recent study.

Immune-related AEs linked to better outcomes in HCC patients

02 Mar 2026

Annual increase in HCC deaths higher among rural vs urban residents

01 Mar 2026

Rural area residents have seen greater increases in hepatocellular carcinoma (HCC) deaths each year than those living in urban areas, reveals a study.

Annual increase in HCC deaths higher among rural vs urban residents

01 Mar 2026

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Endoscopic retrograde cholangiopancreatography (ERCP), although deemed safe, is associated with the highest risk of complications when compared with other endoscopic procedures, reveals a study.

Chronic liver disease ups risk of post-ERCP complications

23 Feb 2026

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

A 15-year study recommends taking into consideration the differential risks of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations when choosing targeted therapies for the treatment of psoriasis and psoriatic arthritis (PsA), particularly in patients with risk factors for viral reactivation.

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

16 Feb 2026

Early PoPH linked to mortality in patients with cirrhosis

12 Feb 2026

The use of the 2022 ESC/ERC definitions of pulmonary arterial hypertension (PAH) has led to the identification of cirrhosis patients with early-stage portopulmonary hypertension (PoPH), who are at greater risk of death, reports a study.

Early PoPH linked to mortality in patients with cirrhosis

12 Feb 2026

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

11 Feb 2026

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), who also happen to have hypertension, are at much greater risk of adverse clinical outcomes and progression of liver stiffness and fibrosis, according to a study.

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

11 Feb 2026

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

11 Feb 2026 bởi

Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

11 Feb 2026

Healthy living in early adulthood may prevent steatotic liver disease in midlife

10 Feb 2026

Maintaining a healthy lifestyle or making lifestyle changes in early adulthood helps reduce the risk of developing steatotic liver disease in midlife, even for individuals with genetic predisposition, as shown in a study.

Healthy living in early adulthood may prevent steatotic liver disease in midlife

10 Feb 2026

Liver supplements popularity on the rise despite limited evidence

03 Feb 2026 bởi

The market for liver supplements is rapidly growing despite lacking scientific evidence to support their efficacy claims, reveals a study.

Liver supplements popularity on the rise despite limited evidence

03 Feb 2026

Tin tức & Cập nhật

Xem bài viết Gan

Xem

Chuyên ngành:

Alcohol drinking even in small amount raises risk of steatotic liver disease

Alcohol drinking even in small amount raises risk of steatotic liver disease

Immune-related AEs linked to better outcomes in HCC patients

Immune-related AEs linked to better outcomes in HCC patients

Annual increase in HCC deaths higher among rural vs urban residents

Annual increase in HCC deaths higher among rural vs urban residents

Chronic liver disease ups risk of post-ERCP complications

Chronic liver disease ups risk of post-ERCP complications

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

Some therapies for psoriasis, PSA linked to HBV, HCV reactivation

Early PoPH linked to mortality in patients with cirrhosis

Early PoPH linked to mortality in patients with cirrhosis

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Hypertension ups risks of adverse outcomes, fibrosis progression in MASLD

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

Healthy living in early adulthood may prevent steatotic liver disease in midlife

Healthy living in early adulthood may prevent steatotic liver disease in midlife

Liver supplements popularity on the rise despite limited evidence

Liver supplements popularity on the rise despite limited evidence